PLoS Computational Biology (Sep 2022)

Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model.

  • Polina Suter,
  • Eva Dazert,
  • Jack Kuipers,
  • Charlotte K Y Ng,
  • Tuyana Boldanova,
  • Michael N Hall,
  • Markus H Heim,
  • Niko Beerenwinkel

DOI
https://doi.org/10.1371/journal.pcbi.1009767
Journal volume & issue
Vol. 18, no. 9
p. e1009767

Abstract

Read online

Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical outcomes and searching for personalized treatments. We present bnClustOmics, a statistical model and computational tool for multi-omics unsupervised clustering, which serves a dual purpose: Clustering patient samples based on a Bayesian network mixture model and learning the networks of omics variables representing these clusters. The discovered networks encode interactions among all omics variables and provide a molecular characterization of each patient subgroup. We conducted simulation studies that demonstrated the advantages of our approach compared to other clustering methods in the case where the generative model is a mixture of Bayesian networks. We applied bnClustOmics to a hepatocellular carcinoma (HCC) dataset comprising genome (mutation and copy number), transcriptome, proteome, and phosphoproteome data. We identified three main HCC subtypes together with molecular characteristics, some of which are associated with survival even when adjusting for the clinical stage. Cluster-specific networks shed light on the links between genotypes and molecular phenotypes of samples within their respective clusters and suggest targets for personalized treatments.